BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright ©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Psychiatry. Jan 19, 2026; 16(1): 111800
Published online Jan 19, 2026. doi: 10.5498/wjp.v16.i1.111800
Differential diagnosis of bipolar II disorder and major depressive disorder: Integrating multimodal approaches to overcome clinical challenges
Yuan-Zi Zou, Ting Chen, Chao-Ban Wang
Yuan-Zi Zou, Department of Pediatrics Intensive Care Unit Nursing, West China Second University Hospital, Sichuan University, Chengdu 610000, Sichuan Province, China
Ting Chen, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610000, Sichuan Province, China
Chao-Ban Wang, Department of Pediatrics Hematology, West China Second University Hospital, Sichuan University, Chengdu 610000, Sichuan Province, China
Co-corresponding authors: Ting Chen and Chao-Ban Wang.
Author contributions: Zou YZ drafted the paper; Chen T drafted and rewritten the paper; Wang CB conception and design, administrative support. Regarding the designation of two co-corresponding authors, we confirm that both Wang CB and Chen T have made substantial and equal contributions to the conceptualization, design, and execution of this review. Throughout the preparation of the manuscript, both authors actively participated in drafting, critically revising all sections, and ensuring the scientific accuracy, coherence, and intellectual rigor of the work. They jointly supervised the project, provided essential guidance, and approved the final version submitted for publication. Given their shared leadership and significant involvement at every stage of the manuscript’s development, it is appropriate to list both as co-corresponding authors. Both take full responsibility for the integrity of the work and are equally available to handle correspondence concerning the published article. This arrangement reflects their equitable contributions and aligns.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Chao-Ban Wang, Department of Pediatrics Hematology, West China Second University Hospital, Sichuan University, No. 1416 Chenglong Avenue, Jinjiang District, Chengdu 610000, Sichuan Province, China. chaobanwang@scu.edu.cn
Received: July 10, 2025
Revised: August 12, 2025
Accepted: October 29, 2025
Published online: January 19, 2026
Processing time: 174 Days and 19.9 Hours
Core Tip

Core Tip: A multidisciplinary approach that combines detailed clinical evaluation, insights into genetic underpinnings, and multimodal assessments using neuroimaging and biomarkers may substantially improve clinicians’ ability to distinguish between major depressive disorder (MDD) and bipolar II disorder (BD-II). Enhanced diagnostic accuracy can lead to more tailored and effective treatment strategies, ultimately improving patients' health outcomes and quality of life. This mini-review aims to summarize current evidence on the distinguishing features of MDD and BD-II-focusing on clinical symptoms, genetic profiles, neuroimaging findings, and biomarker signatures-and discusses the potential of machine learning approaches to further refine and support the differential diagnostic process.